Nicholas Maxwell Fisk (born 1956) is an Australian maternal-fetal medicine specialist, academic and higher education lead.
[1][2] As a researcher, his group has pioneered advances in understanding fetoplacental disease and its treatment, including characterising early human fetal stem cell populations and their lifelong persistence in maternal tissues, documenting “fetal pain” and its blockade by opioid analgesia, and unravelling the vascular basis of twin-to-twin transfusion syndrome.
He returned to Australia in 2008 as the inaugural Director of the Centre for Clinical Research[19] at the University of Queensland, where between 2010-2016 he served as Executive Dean of the Faculties of Health, Medicine and Biomedical Sciences.
[29][30][31][32] Fisk has published over 300 research papers,[33] and served on the editorial boards of PLoS Medicine and Human Reproduction.
As an influential clinician, he is known for promoting the natural caesarean operation,[34][35][36][37] and as an advocate for women’s right to choose their mode of delivery.